Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV)
Insurance Circular Letter No. 2017-11 provides guidelines for life insurance underwriting regarding applicants with actual, perceived, or suspected HIV status in the Philippines. Insurers may require voluntary HIV testing and must report positive results to the Medical Information Database, adhering to privacy laws. Coverage can be granted if the applicant is undergoing proper treatment and meets specific medical criteria, including recent CD4 counts and viral load tests. Additional underwriting requirements may be imposed, and applications can be denied based on co-morbidities or other risk factors unrelated to HIV. The circular emphasizes the need for compliance with existing laws and takes effect immediately.
Quick Answers
- What is Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV) about?
- Insurance Circular Letter No. 2017-11 provides guidelines for life insurance underwriting regarding applicants with actual, perceived, or suspected HIV status in the Philippines. Insurers may require voluntary HIV testing and must report positive results to the Medical Information Database, adhering to privacy laws. Coverage can be granted if the applicant is undergoing proper treatment and meets specific medical criteria, including recent CD4 counts and viral load tests. Additional underwriting requirements may be imposed, and applications can be denied based on co-morbidities or other risk factors unrelated to HIV. The circular emphasizes the need for compliance with existing laws and takes effect immediately.
- What type of law is Insurance Circular Letter No. 2017-11?
- Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV) (Insurance Circular Letter No. 2017-11) is a Philippine Other Rules and Procedures enacted by the Congress of the Philippines.
- When was Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV) enacted?
- Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV) (Insurance Circular Letter No. 2017-11) was enacted on Feb 14, 2017.
- What is the citation for Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV)?
- Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV), Insurance Circular Letter No. 2017-11, Feb 14, 2017 (Philippines)
Law Information
- Reference Number
- Insurance Circular Letter No. 2017-11
- Date Enacted
- Category
- Other Rules and Procedures
- Subcategory
- Insurance
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
February 14, 2017
INSURANCE CIRCULAR LETTER NO. 2017-11
| TO | : | All Life Insurance Companies Authorized to Transact Business in the Philippines |
| SUBJECT | : | Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV) |
Pursuant to the powers vested in the Insurance Commissioner by Section 437 of the Insurance Code, as amended by Republic Act No. 10607, the following guidelines which were formulated after due consultation with the industry, shall be observed in the assessment of risks of persons with actual, perceived or suspected to be with HIV so as to determine the parameters to be considered for life insurance risk classification and other underwriting purposes: DETACa
1. Voluntary HIV Testing. The insurer may require applicants to undergo HIV testing based on parameters such as but not limited to age, total amount at risk, occupation/lifestyle, provided that the applicant/proposed insured voluntarily consented to such testing pursuant to Article III of R.A. 8504, Philippine AIDS Prevention and Control Act of 1998, performed by health facilities recognized by the Department of Health (DOH) and equipped in providing services on HIV testing and counselling.
2. Report to the Medical Information Database. The insurer shall report to the Medical Information Database (MID) any HIV test with positive results, provided the information was voluntarily submitted by the applicant/proposed insured and subject to compliance by the insurer with the provisions of R.A. No. 10173 or the Data Privacy Act of 2012, and provided further, that the report to the MID is done with the knowledge of the applicant/proposed insured.
3. Evaluation of Compliance with Treatment. The insurer may postpone the acceptance of newly discovered HIV (+) positive individuals for a period of not more than one (1) year from the start of continuous Anti-Retro Viral Treatment (ART) in order to evaluate compliance and efficacy of treatment.
4. Grant of Insurance Coverage. The insurer may provide insurance coverage to a person with HIV or an individual diagnosed to be infected with HIV, if (a) the person is undergoing proper medical treatment, (b) the person has a favorable risk profile and (c) the results of the medical examinations required by the insurer are within normal limits. The requirements may include the following:
4.1. Routine requirements based on the age and total amount at risk;
4.2. HIV Medical Questionnaire filled out by the attending physician; HEITAD
4.3. Three (3) consecutive tests for CD4 cell count not older than 6 months (submission of copies of results is required);
4.4. Current Viral Load count (Plasma HIV-1 RNA) not older than 6 months (submission of copy of result is required);
4.5. Treatment or therapy course, must be undergoing Anti-Retro Viral Treatment (ART);
4.6. Hepatitis B profile;
4.7. Hepatitis C profile;
4.8. Regular blood chemistry profile including liver & kidney function tests;
4.9. Non-smoker;
4.10. Chest x-ray must be normal results, without pulmonary tuberculosis (PTB) or other pulmonary infections;
4.11. No early signs of other co-morbidities such as renal disease and/or Coronary Artery Disease (CAD);
4.12. No signs of opportunistic infections.
The insurer shall have the right to require all original or certified photocopies of the above medical requirements.
5. Additional Underwriting Requirements. The insurer may request for additional documents or evidence of insurability, whether medical or financial, which may be necessary for the proper underwriting of the application.
6. Cost of Special Underwriting Requirements. The insurer may require applicants to defray the cost of special underwriting requirements related to the application for insurance coverage, if necessary.
7. Imposition of Additional Mortality Charges. The insurer may, upon prior approval of this Commission, impose extra mortality charges to persons accepted for coverage under Item 4 of this Guidelines. The coverage may provide supplemental benefits or riders.
8. Modification of Plan Benefits and Terms. The insurer may, upon prior approval of this Commission, set limits of acceptance for persons with HIV as to plan of insurance, maturity term, payment term, age, and policy amount. aDSIHc
9. When Application may be Denied. The insurer may postpone or decline the application of persons with HIV when presented with co-morbidities, medical conditions or other risk factors, not on the basis of their being positive for HIV but on the basis of such co-morbidity, medical condition or other risk factor which by itself alone (i.e., even without being HIV positive) would lead to the same underwriting decision based on the insurer's underwriting guidelines. Such risk profiles, but not limited to, are as follows:
9.1. With co-morbidities (kidney, liver, or cardiovascular diseases);
9.2. With Hepatitis B or C;
9.3. With PTB;
9.4. With signs of opportunistic infections;
9.5. Smoker (present or history);
9.6. Injecting drug (illegal) users (present or history);
9.7. Other declinable medical conditions (e.g., Chronic Kidney Failure, uncontrolled Diabetes and/or Hypertension, Cancer under Stage 4 or with presence of metastases);
9.8. Declinable occupational risk;
9.9. Declinable geographical/territorial risk;
9.10. Declinable avocation (dangerous hobbies) risk;
9.11. Declinable financial profile risk.
This Circular shall take effect immediately.
For strict compliance.
(SGD.) DENNIS B. FUNAInsurance Commissioner
Cite This Law
Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV), Insurance Circular Letter No. 2017-11, Feb 14, 2017 (Philippines)
Guidelines in the Life Underwriting of Applicants with Actual, Perceived or Suspected to be with Human Immunodeficiency Virus (HIV), Insurance Circular Letter No. 2017-11 (Phil. 2017)
Related Laws
- Guidelines in the HMO Underwriting of Applicants with Actual, Perceived, or Suspected HIV StatusInsurance Circular Letter No. 2019-30 • Jun 21, 2019 • Other Rules and Procedures
- Revised Policies and Guidelines on the Use of Antiretroviral Therapy (ART) Among People Living with Human Immunodeficiency Virus (HIV) and HIV-Exposed InfantsDOH Administrative Order No. 2018-0024 • Oct 24, 2018 • Other Rules and Procedures
- Guidelines on the Formulation and Implementation of the HIV and AIDS Prevention and Control Policy Program in the DFADFA Department Order No. 09-13 • May 20, 2013 • Other Rules and Procedures
- Guidelines on Antiretroviral Therapy among Adults and Adolescents with Human Immunodeficiency Virus InfectionDOH Administrative Order No. 2009-0006 • Jan 13, 2009 • Other Rules and Procedures
- Guidelines in the Application of the Workplace Component of RA 8504 (Philippine AIDS Prevention and Control Act of 1998)DOLE Memorandum Circular No. 002-00 • Jun 19, 2000 • Other Rules and Procedures
- Guidelines for the Implementation of STI, HIV and AIDS Prevention and Control Policy and Program in the Philippine National PolicePNP Memorandum Circular No. 002-12 • Mar 26, 2012 • Other Rules and Procedures
Browse More Other Rules and Procedures
Explore other laws in the Other Rules and Procedures category.
View All Other Rules and ProceduresNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law